Clinical Trial Update: Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy [Phase 3]

View source ↗

Summary

This clinical trial update outlines a Phase 3 study evaluating TNTL for non-proliferative diabetic retinopathy. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• TNTL

Snippet

Sponsor: Beletalent (Zhuhai) Pharmaceutical Co., Ltd | Conditions: Non-Proliferative Diabetic Retinopathy | Phase 3 | Status: RECRUITING